124 related articles for article (PubMed ID: 9278940)
1. [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].
Koga M; Miyata H; Tsuno N; Nakayama K; Ushijima S; Tanaka Y; Hiraga Y; Kobayashi N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):143-7. PubMed ID: 9278940
[TBL] [Abstract][Full Text] [Related]
2. [Association between Distigmine-induced Adverse Events and Serum Butyrylcholinesterase Level: A Multicenter Retrospective Study].
Mitsuboshi S; Otaki S; Kaneko C; Tsuruma N
Yakugaku Zasshi; 2022; 142(9):993-998. PubMed ID: 36047226
[TBL] [Abstract][Full Text] [Related]
3. Blood acetylcholinesterase and butyrylcholinesterase as biomarkers of cholinesterase depression among pesticide handlers.
Strelitz J; Engel LS; Keifer MC
Occup Environ Med; 2014 Dec; 71(12):842-7. PubMed ID: 25189163
[TBL] [Abstract][Full Text] [Related]
4. Effect of distigmine bromide on the central cholinergic system.
Nakayama K; Katsu H; Kitazumi K
J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy.
Suzuki K; Miyamoto T; Miyamoto M; Hirata K
Intern Med; 2008; 47(10):983-4. PubMed ID: 18480587
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
[TBL] [Abstract][Full Text] [Related]
7. [Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Takahashi M; Ubukata S; Sato E; Shoji M; Morikawa N; Watanabe H; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2011 Dec; 49(12):877-84. PubMed ID: 22352046
[TBL] [Abstract][Full Text] [Related]
8. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
Tvarijonaviciute A; Ceron JJ; Tecles F
Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
[TBL] [Abstract][Full Text] [Related]
11. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
12. [Cholinergic crisis following administration of distigmine bromide: a case report].
Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
[TBL] [Abstract][Full Text] [Related]
13. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
Kobayashi K; Sekiguchi H; Sato N; Hirose Y
Chudoku Kenkyu; 2016 Mar; 29(1):26-9. PubMed ID: 27255021
[TBL] [Abstract][Full Text] [Related]
14. Effect of Patient Age, Dose, and Chronic Kidney Disease on the Risk of Adverse Reactions to Distigmine.
Mitsuboshi S; Nagai K; Okajima H
Biol Pharm Bull; 2020; 43(8):1275-1278. PubMed ID: 32741950
[TBL] [Abstract][Full Text] [Related]
15. Variable response of cholinesterase activities following human exposure to different types of organophosphates.
Moon J; Chun B; Lee S
Hum Exp Toxicol; 2015 Jul; 34(7):698-706. PubMed ID: 25712411
[TBL] [Abstract][Full Text] [Related]
16. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
[TBL] [Abstract][Full Text] [Related]
17. Comparison of methods used for the determination of cholinesterase activity in whole blood.
Naik RS; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
[TBL] [Abstract][Full Text] [Related]
18. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Tada M; Fujita N; Umeda M; Koike H; Nagai H
No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
[TBL] [Abstract][Full Text] [Related]
19. [Patients confined in bed for an extended period and developing cholinergic crisis following administration of distigmine bromide: report of 3 cases].
Tadara R; Kobayashi M; Nakamura N; Suzuki Y; Isono S
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1566-7. PubMed ID: 9780688
[No Abstract] [Full Text] [Related]
20. Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.
Karasova JZ; Maderycova Z; Tumova M; Jun D; Rehacek V; Kuca K; Misik J
Toxicol Lett; 2017 Aug; 277():24-31. PubMed ID: 28465191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]